Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines.
about
Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like propertiesCD133 (Prominin) negative human neural stem cells are clonogenic and tripotentHigher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIBMonoclonal Antibodies 13A4 and AC133 Do Not Recognize the Canine Ortholog of Mouse and Human Stem Cell Antigen Prominin-1 (CD133)Enhanced connexin 43 expression delays intra-mitotic duration and cell cycle traverse independently of gap junction channel function.CD133 is a modifier of hematopoietic progenitor frequencies but is dispensable for the maintenance of mouse hematopoietic stem cells.Cancer stem cells in solid tumors: elusive or illusive?The therapeutic promise of the cancer stem cell concept.Integrin alpha 6 regulates glioblastoma stem cells.Identification and targeting of cancer stem cells.Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheresCancer stem cells, cancer cell plasticity and radiation therapyTenascin-C: a novel candidate marker for cancer stem cells in glioblastoma identified by tissue microarraysCoexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like CellsCD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma.Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.Characterization of the conversion between CD133+ and CD133- cells in colon cancer SW620 cell lineCD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.A quest for initiating cells of head and neck cancer and their treatment.Cancer stem cells in brain tumor biology.Cancer stem cells: cell culture, markers, and targets for new therapies.Maternal embryonic leucine zipper kinase is upregulated and required in mammary tumor-initiating cells in vivo.Glioblastoma, cancer stem cells and hypoxia.Biological challenges of BRAF inhibitor therapyHigh-content screening for the discovery of pharmacological compounds: advantages, challenges and potential benefits of recent technological developments.CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges.Cell adhesion molecules and their relation to (cancer) cell stemness.Emerging importance of dietary phytochemicals in fight against cancer: Role in targeting cancer stem cells.Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells.A metabolic signature of colon cancer initiating cells.CD133, Stem Cells, and Cancer Stem Cells: Myth or Reality?CD133 and CD133-regulated nucleophosmin linked to 5-fluorouracil susceptibility in human colon cancer cell line SW620.Immunotoxin targeting CD133(+) breast carcinoma cells.Automatic cell cloning assay for determining the clonogenic capacity of cancer and cancer stem-like cells.The PI3K/AKT signaling pathway controls the quiescence of the low-Rhodamine123-retention cell compartment enriched for melanoma stem cell activity.CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitope.Resistance to hypoxia-induced, BNIP3-mediated cell death contributes to an increase in a CD133-positive cell population in human glioblastomas in vitro.Pancreatic carcinoma cell lines reflect frequency and variability of cancer stem cell markers in clinical tissue.Expression of CD133 in SW620 colorectal cancer cells is modulated by the microenvironment.
P2860
Q21562142-A33E369E-9BAD-4098-BFE3-48CB32A10922Q21562426-D1028B18-4505-42B1-8B46-7DDEC12AD9B3Q24645020-998669A4-42AD-4AA7-A605-F884E791E53FQ27320830-E0D8CD29-D42D-4665-B736-EF2720BB2954Q30433411-3A61E949-D849-4945-B1E1-D88CE0204197Q30538464-338A64CC-2FE1-4373-A1A3-28F5FA33601DQ33349066-A1599B79-8B39-4426-994A-828D86AE3889Q33559711-1C27A65E-B1A5-4EEF-894F-4459A683D6D1Q33908472-F72FFB61-1D02-4DF7-BD33-0F03FE407969Q33921460-66C4C981-DA92-4D84-91DB-0A6CF0CA1691Q34087018-5F2493A2-B73F-40EC-9A5B-89B74963F791Q34921599-25243406-A9A0-41A0-A14E-B1C70D69482EQ35060849-34AB8333-368D-4035-A253-40610F38E693Q35573268-CD86A0EA-E195-4F15-9092-0B5ADEE236ECQ35666904-BD3D1321-26EE-4509-A197-1957E3EAC450Q36041205-C009F21D-76FE-4B48-B839-3116AF7C04F7Q36291579-BD2190AD-B106-4F84-AEB8-198590DBF686Q36524202-08C9E2FD-EBC8-46AF-B58E-FB3F2740F973Q36861663-5EEB60D0-626B-4A84-A166-F60D4C57BF4FQ37334258-BA9B2694-CA49-49A4-9EEF-B552D39BCCF6Q37426166-87F37BA5-97AE-4598-8FBA-EDF07A484B64Q37598736-37FC938F-E594-440E-A5BC-553A6F3D8268Q37708563-AAB98A0D-930D-4A51-B3CC-9935BEA7C73FQ37807468-2FFEDBE5-D96D-4B33-9A69-CEAB4CA8A70BQ37851738-665A3A40-6BA4-4722-A9DA-92C41BDC008DQ38028519-61B114F0-9D09-41F8-8FE4-6E93CCD03D56Q38035206-03E2E483-6491-4B75-979D-687002C2BF58Q38188463-C55A95AD-9BE1-4042-8BD7-CD35B4F85A2CQ38725554-B1CF3CCE-BE7A-4824-9A42-BA7689D588E0Q38908575-70AA2E1C-1A75-4F0A-A140-E2857375814CQ38922156-A9BCC403-CE87-47B2-9B48-DE11FFFDEAE1Q38922806-A43B95F3-C0BB-4ED3-BABB-AD992045E07DQ39043127-ECB25D02-1AB6-4E81-AC84-0E6A69C3B603Q39173834-F709F2E3-7941-4780-BD09-EE839E59BBD3Q39186965-AC919653-29B7-4793-8C10-7DACB0410492Q39203640-AD638EBA-2B0D-45A0-87B8-349580219826Q39243687-B1549510-366E-485C-B5F9-81C1DE38565FQ39245618-1BA4423A-4C6F-4B2B-9DA9-C06380F4D822Q39285522-D270CBBC-0D73-4AAF-9346-BEBEB73CE1DDQ39312637-81EAE564-021F-4040-87D2-AE002689B05F
P2860
Cell cycle-dependent variation of a CD133 epitope in human embryonic stem cell, colon cancer, and melanoma cell lines.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cell cycle-dependent variation ...... ncer, and melanoma cell lines.
@en
type
label
Cell cycle-dependent variation ...... ncer, and melanoma cell lines.
@en
prefLabel
Cell cycle-dependent variation ...... ncer, and melanoma cell lines.
@en
P2093
P2860
P1433
P1476
Cell cycle-dependent variation ...... ncer, and melanoma cell lines.
@en
P2093
Jorge Múnera
Marie Jaksch
Robert G Oshima
Ruchi Bajpai
P2860
P304
P356
10.1158/0008-5472.CAN-08-0723
P407
P577
2008-10-01T00:00:00Z